Investigation Into Delay to Diagnosis of Alzheimer's Disease With Exelon (InDDEx)

NCT00000174 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Alzheimer Disease
Cognition Disorders

Interventions

DRUG: Rivastigmine

Sponsor

Novartis